Induction to Labour With Double Cervical Ballon at Home Versus at Hospital

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

834 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-27

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial\] is to compare the outcomes between induction to labour at home versus hospitalized. The main questions it aims to answer are:

* Can the induction to labour at home with cervical rippening ballon increase the vaginal delivery rate?
* Will the induction to labour at home increase maternal satisfaction
* Will the induction to labour at home improve medical circuits and coulb it be cost effective? Participants who meet inclusion criteria will undergo randomization so as to be asignated an induction to labour at home or in the hospital.

Researchers will compare both labour induction groups to see if the induction to labour at home has better outcomes as described previously.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness and Safety of Induction of Labour Using a Double Balloon Catheter (INDOBA)

NCT04163744

Induction of Labour

UNKNOWN

Outpatient Transcervical Balloon For Induction of Labor

NCT05798728

Induced Vaginal Delivery Induced; Birth

UNKNOWN NA

Comparing Outpatient and Inpatient Use of a Cervical Balloon for Starting Labor in Low-Risk Pregnancies.

NCT06983535

Induction of Labor

TERMINATED NA

Comparison Between Two Medical Devices for Labor Induction After Previous C-section

NCT06506721

Delivery, Obstetric Cesarean Section Obstetric Delivery

RECRUITING NA

Outpatient Induction of Labour Using a Double Balloon Transcervical Catheter in Low-risk Pregnant Women: a Two-centre Open Prospective Randomised Controlled Trial - OutCRIB

NCT07265518

Pregnant Women

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

INDOBAMHOS is a multicentric randomized clinical trial which is based in the principle that cervical rippening with intracervical probes with ballons is as safe as pharmacological induction with PGE2 and it seems to be a suitable option to develop the cervical rippening process of the induction at home rather than in the hospital.

The purpouse of the study is to demonstrate that the comfort of performing the cervical rippenning at home will benefit patients with an increase of the vaginal delivery rate and increases maternal satisfaction. And also will improve medical circuits and could be cost-effective when compared to hospitalized labour induction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Induced; Birth Cervical Dilatation Live Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

At home patients group

After insertion of the Cervical Rippening Balloon and checking fetal and maternal well-being, the patient will go home between 6 and 8 hours to complete the cervical rippening process. The patient will remove autonomously the balloon and will go to the hospital one hour later, where the induction will continue.

Group Type EXPERIMENTAL

Cervical rippening at home

Intervention Type DEVICE

The experimental arm of the study will undergo cervical rippening at home between 6 and 8 hours and then will come back to the hospital to continue with the labor induction

Hospitalized patients group

After the insertion of the Cervical Rippening Balloon and verifications of the fetal and materna well-being, the patient will undergo the cervical rippening process for between 6 and 8 hours in the hospital and will remain hospitalized until the time of the delivery.

Group Type ACTIVE_COMPARATOR

Cervical rippening in the hospital

Intervention Type DEVICE

The active comparator arm of the study will undergo cervical rippening in the hospital between 6 and 8 hours and then will remain there to continue with the labor induction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cervical rippening at home

The experimental arm of the study will undergo cervical rippening at home between 6 and 8 hours and then will come back to the hospital to continue with the labor induction

Intervention Type DEVICE

Cervical rippening in the hospital

The active comparator arm of the study will undergo cervical rippening in the hospital between 6 and 8 hours and then will remain there to continue with the labor induction

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women with ages \>18 y.o
* Being able to read and understand the informed consent
* Accept to join the study when signing the informed consent
* Singleton
* Cephalic presentation
* Weeks of gestation between equal or more than 37 and less than 42
* Low risk indication of labor induction: Cronologically prolonged gestation
* Intermediate risk indication of labor induction: Macrosoma, Elevated maternal age, Intrahepatic Gestacional Colestasis, Gestational Diabetes Mellitus treated with diet, Gestational Diabetes Mellitus with insulin therapy and correct metabollic controls, Small for gestacional age fetus, Stable chronic hypertension, anterior caesarean section

Exclusion Criteria

* Premature rupture of membranes (PROM)
* Breech presentation
* Unstable presentation
* Polihydramnios
* Severe congenital fetal afection
* Fetal growth restriction
* Suspected fetal well-being loss on CTG
* Bishop score equal or higher than seven before insertion of the CRB
* High cephalic presentation
* Home further than 30min from Hospital
* Preeclampsia
* Diabetes Mellitus type 1
* Maternal Hypertension
* Other maternal pathology with severe compromise
* Vaginal delivery Exclusion:
* Oclusive and non-occlusive placenta previa (marginal or low insertion)
* Vasa previa
* Transverse / Oblique situation
* Cord prolapse
* History of previous caesarean section with uterine incission in inverted T
* History of uterine rupture
* Two or more previous Caesarean section
* Active genital herpetical infection

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR